Women Weren’t Counted: How Medicine Ignored Female Biology

For much of modern medicine’s history, women’s health wasn’t included in the scientific process. Healthcare systems, clinical research, and medical training were built around male bodies, and female biology was treated as an outlier. That historical dismissal has shaped today’s gaps in women’s health, fueling medical gaslighting and distrust among women who are told their symptoms are “in their head.” 

The Legacy of Exclusion in Medical Research

Until the 1990s, clinical research routinely excluded women from virtually all major studies unless the condition was reproductive in nature. In the U.S., a 1977 FDA guideline barred women of childbearing potential from most early-phase clinical trials, a policy that excluded many women entirely from research participation. This was done under the guise of protecting potential pregnancies and avoiding hormonal variability. Findings from male-only research were generalized to all humans, leaving women’s particular biological responses unexamined.

A systematic review of medical research gaps found that studies historically excluded female subjects—whether human or animal—and then assumed that male biology was the default norm. These choices stemmed from implicit bias and structural norms that favored male subjects and minimized the importance of female physiology.

The result? A shortage of evidence on how diseases develop, how symptoms surface, and how treatments take—or fail to take—effect in female bodies.

“Hysterical”: Language, Bias, and the Dismissal of Women’s Concerns

This bias seeped into every corner of clinical practice. For centuries, women’s health complaints—from pain to persistent fatigue to pressing cardiovascular symptoms—were dismissed as psychological or emotional. Doctors doubted, dismissed, and downplayed their concerns. Early medical language even coined terms like hysteria, derived from hystera, meaning womb, pathologizing female biology as irrational.

Today, research across healthcare settings confirms this pattern. Studies show women are more likely than men to have symptoms minimized or attributed to anxiety rather than serious pathology. Qualitative analyses link this to gendered norms in clinical settings: providers may unintentionally view women’s pain and symptoms through stereotypes rather than biological curiosity.

Contemporary research reveals that medical gaslighting can lead women to delayed care and worsened health outcomes because early warning signs go uninvestigated. 

When women’s symptoms are dismissed or misattributed:

• Diagnoses are delayed, sometimes catastrophically.

• Women are more likely to be told their pain is psychological rather than physical.

• Medical data remain skewed, leaving clinicians with less evidence to guide treatment in female patients.

Why This Matters for Hormones and Modern BHRT

Understanding this history reframes how we think about women’s health decisions today, especially for life phases like perimenopause and menopause, which have traditionally been under-researched. Hormones are not peripheral to health — they influence metabolism, cardiovascular function, and immune responses, yet they were often excluded altogether in research design. That legacy has profoundly shaped clinical blind spots regarding conditions like perimenopausal cardiovascular risk profiles, metabolic changes, and chronic inflammation.

Modern bioidentical hormone replacement therapy (BHRT) exists in part because of this gap. Women need care models that integrate female-specific biology into the diagnostic process, rather than retrofitting male-centric models onto female patients.

A Way Forward

Recognizing that women were historically dismissed is about acknowledging that these patterns were systems of omission with real consequences. The medical community now broadly recognizes sex as an important biological variable in research, and policies increasingly mandate inclusion. But the gaps persist, and without conscious effort, they will continue to shape the patient experience.

Women’s health history is a living legacy—one that still shapes how symptoms are seen, how research is written, and how care is delivered. When women are finally heard and counted, medicine moves forward, medicine becomes better, and medicine is practiced the way it was meant to be.